- CA$1.32bn
- CA$2.80bn
- $2.69bn
- 55
- 83
- 57
- 71
2019 December 29th | 2020 December 27th | 2022 January 2nd | 2023 December 31st | R2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,893 | 2,419 | 2,344 | 2,685 | 2,061 |
Cost of Revenue | |||||
Gross Profit | 413 | 153 | 187 | 221 | 49.1 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,720 | 2,501 | 2,298 | 2,698 | 2,349 |
Operating Profit | 173 | -81.3 | 46 | -12.3 | -288 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 99.7 | -156 | -4.93 | -169 | -324 |
Provision for Income Taxes | |||||
Net Income After Taxes | 67.7 | -134 | -6.93 | -150 | -296 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 57.7 | -158 | -14.5 | -136 | -276 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 57.7 | -158 | -14.5 | -136 | -276 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.09 | -1.89 | -0.492 | -1.75 | -2.81 |
Dividends per Share |